Childhood obesity workshop planned
Dr. Meredith Brazell, pediatrician at Camden Pediatrics, a Southeast Georgia Physician Associates-Camden Pediatrics will host a workshop titled, “Preventing Childhood Obesity One Step at a Time” at the Southeast Georgia Health System Camden Campus Conference Center. It will be held from noon to 1 p.m. April 24.
To register for the lecture, call 1-855-ASK-SGHS (1-855-275-7447); a free light lunch will be provided.
Tai Chi and Qigong Day planned
The Golden Isles Tai Chi Club on St. Simons Island will celebrate Universal Tai Chi and Qigong Day at 10 a.m. April 28 at the Golden Isles Tai Chi Club at Glynn Visual Arts Center, 106 Island Drive, St. Simons Island. Anyone interested in Tai Chi is welcome. Groups who would like to participate are also welcome. For more information, call 912-634-0815.
Fun run planned for Saturday
Golden Isles Track Club will host a beach/trail fun run at 8 a.m. Saturday beginning and ending at the East Beach bath house at the Coast Guard Station on St. Simons Island. The race will include beach access trails, beach and street pavement. There is no fee, but participants should bring non-perishable food items for Sparrow’s Nest Food Bank. Refreshments will be provided. For more information, call 912-268-2740.
Study: Fish oil capsules don’t help dry eye symptoms
Many doctors recommend them, but fish oil supplements failed to help people with dry eye when put to a scientific test.
About 14 percent of U.S. adults have dry eye, which causes pain and vision problems. It’s more common in women and with age, and is related to inflammation.
Omega-3 fatty acids in fish oil may reduce inflammation, so doctors thought they might help more than the artificial tears, eyedrops and other treatments patients use now.
A federally funded study gave 500 people daily doses of fish oil or dummy capsules. After one year, dry eye symptoms were similar in both groups.
Results were discussed Friday at a conference in Washington and published by the New England Journal of Medicine.
Immune therapy scores big win against lung cancer in study
CHICAGO — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
In the study, Merck’s Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone after nearly one year. The results are expected to quickly set a new standard of care for about 70,000 patients each year in the United States whose lung cancer has already spread by the time it’s found.
— The Brunswick News and